当前位置: X-MOL 学术JAMA Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography.
JAMA Neurology ( IF 20.4 ) Pub Date : 2023-04-03 , DOI: 10.1001/jamaneurol.2023.0455
Gillian T Coughlan 1 , Tobey J Betthauser 2, 3 , Rory Boyle 1 , Rebecca L Koscik 2, 3 , Hannah M Klinger 1 , Lori B Chibnik 1, 4 , Erin M Jonaitis 2, 3 , Wai-Ying Wendy Yau 1 , Allen Wenzel 3 , Bradley T Christian 2 , Carey E Gleason 2 , Ursula G Saelzler 5 , Michael J Properzi 1 , Aaron P Schultz 1, 6 , Bernard J Hanseeuw 1, 6, 7, 8, 9 , JoAnn E Manson 4 , Dorene M Rentz 1, 6 , Keith A Johnson 6, 8 , Reisa Sperling 1, 6 , Sterling C Johnson 2, 3 , Rachel F Buckley 1, 6, 10
Affiliation  

Postmenopausal females represent around 70% of all individuals with Alzheimer disease. Previous literature shows elevated levels of tau in cognitively unimpaired postmenopausal females compared with age-matched males, particularly in the setting of high β-amyloid (Aβ). The biological mechanisms associated with higher tau deposition in female individuals remain elusive.

中文翻译:


更年期年龄与 Tau 和 β-淀粉样蛋白正电子发射断层扫描激素治疗的关系。



绝经后女性约占所有阿尔茨海默病患者的 70%。先前的文献显示,与年龄匹配的男性相比,认知未受损的绝经后女性的 tau 蛋白水平升高,尤其是在 β-淀粉样蛋白 (Aβ) 高的情况下。与女性个体中较高的 tau 沉积相关的生物学机制仍然难以捉摸。
更新日期:2023-04-03
down
wechat
bug